title: Intravitreal injection of erythropoietin glycosylation analogs does not protect rod photoreceptor cells from light-induced damage.
authors.affiliation: Department of Ophthalmology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. mtanito@med.shimane-u.ac.jp
authors.forename: Masaki
authors.initials: M
authors.lastname: Tanito
authors.forename: Feng
authors.initials: F
authors.lastname: Li
authors.forename: Robert E
authors.initials: RE
authors.lastname: Anderson
mesh_terms: D000818:Animals; D000068256:Darbepoetin alfa; D004596:Electroretinography; D004921:Erythropoietin / Q000031:analogs & derivatives* / Q000494:pharmacology; D006031:Glycosylation; D006397:Hematinics / Q000494:pharmacology; D058449:Intravitreal Injections; D008027:Light / Q000009:adverse effects*; D018696:Neuroprotective Agents / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D012162:Retinal Degeneration / Q000188:drug therapy* / Q000473:pathology / Q000517:prevention & control*; D017948:Retinal Rod Photoreceptor Cells / Q000187:drug effects* / Q000473:pathology / Q000528:radiation effects*; D017211:Treatment Failure
chemical_list: D006397:Hematinics; D018696:Neuroprotective Agents; D004921:Erythropoietin; D000068256:Darbepoetin alfa